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A Type 4b secretion system (T4bSS) is required for
Legionella growth in alveolar macrophages. IcmQ
associates with IcmR, binds to membranes, and
has a critical role in the T4bSS. We have now solved
a crystal structure of IcmR-IcmQ to further our under-
standing of this complex. This structure revealed an
amphipathic four-helix bundle, formed by IcmR and
the N-terminal domain of IcmQ, which is linked to a
novel C-terminal domain of IcmQ (Qc) by a linker
helix. The Qc domain has structural homology with
ADP ribosyltransferase domains in certain bacterial
toxins and binds NAD+ with a dissociation constant
in the physiological range. Structural homology
and molecular dynamics were used to identify an
extended NAD+ binding site on Qc, and the resulting
model was tested by mutagenesis and binding
assays. Based on the data, we suggest that IcmR-
IcmQ binds to membranes, where it may interact
with, or perhaps modify, a protein in the T4bSS
when NAD+ is bound.
INTRODUCTION
Legionella pneumophila (Lp) is a Gram-negative pathogen of
freshwater amoeba (Fields, 1996) that infects alveolar macro-
phages in humans exposed to contaminated aerosols. After
internalization, Lp evades the lysosome-endosome pathway
and converts the vacuole into a safe haven for replication (Hor-
witz, 1983a, 1983b; Isberg et al., 2009). This process requires
the translocation of protein effectors into the host cell by a
Type IVb secretion system (T4bSS) (Christie and Vogel, 2000;
Luo and Isberg, 2004; de Felipe et al., 2008; Ensminger and
Isberg, 2009). Successive cycles of bacterial uptake, replication,
and cell lysis may cause a severe pneumonia known as Legion-
naire’s disease (Horwitz, 1983a, 1983b; Coers et al., 2000).
The T4bSS is encoded by roughly 26 dot/icm genes that are
required for pathogenicity (Marra et al., 1992; Berger and Isberg,
1993; Segal and Shuman, 1997). Nineteen of the Dot/Icm genes
share sequence homology to genes in bacterial conjugation sys-Structure 21, 1361tems, such as the R64 IncI and Col1b-P9 plasmids that export
DNA (Vogel et al., 1998; Segal and Shuman, 1999). However,
the primary job of the Dot/Icm translocase is to export protein
effectors into the cytoplasm of host cells during infection (Vogel
et al., 1998; Nagai et al., 2005). At least 240 proteins have
carboxyl-terminal signal sequences that allow translocation by
the Dot/Icm system (Zhu et al., 2011). These effectors target a
variety of host proteins that control secretory traffic, translation,
and cell survival to promote the formation of a replication vacuole
(see Isberg et al., 2009).
Seven Dot/Icm proteins have no obvious sequence homology
with known protein families. IcmR and IcmQ are members of
this group and may have a unique role in the T4bSS. IcmQ
is also present in T4bSS of Rickettsia, Fluoribacter, Tatlockia,
Bartonella, and Coxiella. Conversely, the icmR gene is not well
conserved in these genera, although a putative IcmQ partner
is present in all cases. These partners have been designated
as FIR proteins (functional homologs of IcmR) (Feldman and
Segal, 2004; Feldman et al., 2005). L. pneumophila strains
harboring icmQ knockouts are killed by host cells, while those
lacking a functional fir gene have a severe growth defect (Coers
et al., 2000).
IcmR and IcmQ form a stable heterodimer and are localized to
the Lp cytoplasm (Coers et al., 2000), where IcmR may act as a
chaperone to prevent aggregation or nonspecific interactions of
IcmQ with other components (Dume´nil and Isberg, 2001; Dume´-
nil et al., 2004; Raychaudhury et al., 2009). Protease digestion
has shown that the middle of IcmR (Rm) interacts with the N-ter-
minal region of IcmQ (Qn; Figure 1A) (Dume´nil et al., 2004). These
studies revealed the presence of a protease-resistant C-terminal
domain of IcmQ (Qc). A previous crystal structure of interacting
IcmR and IcmQ domains revealed a parallel four-helix bundle
(Raychaudhury et al., 2009), in which Rm forms a helix-turn-helix
motif that interacts with a similar motif in Qn through extensive
hydrophobic contacts. The pattern of hydrophobic residues in
IcmR is conserved in other FIR proteins, which suggests that
FIR-IcmQ complexes in general will form a similar four-helix
bundle (Raychaudhury et al., 2009).
To improve our understanding of this system, we crystallized
full-length IcmQ with Rm and solved the structure of this
complex. The resulting structure revealed the Rm-Qn four-
helix bundle (Raychaudhury et al., 2009), an extended linker
helix, and a C-terminal domain of IcmQ with a previously
unknown fold. The Qc domain shares considerable structural–1373, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1361
Figure 1. Overview, Purification, and Structure of Rm-IcmQ
(A) A domain diagram for IcmR-IcmQ is shown. Trypsin treatment removes flexible N- and C-terminal regions of IcmR that may be unstructured and yields the
trypsin-resistant (tr) Rm-IcmQ complex.
(B) The purification of Rm-IcmQ-tr is shown on SDS-PAGE.Molecular weight markers (LaneM), high speed lysate (Lane 1), eluate fromHisTrap HP (Lane 2), flow-
through from HiTrap Q (Lane 3), eluate from HiTrap Sp (Lane 4), and Rm-IcmQ after trypsinization and purification (Lane 5) are shown.
(C) Amolecularmodel of Rm-IcmQ is shown. Themiddle region of IcmR (Rm, pink) interacts with the N-terminal domain of IcmQ (Qn, light blue) to form the Rm-Qn
interacting domain, comprised of a 4-helix bundle. A linker helix (a2L) separates Rm-Qn from the C-terminal domain of IcmQ (Qc, green). Secondary structures
are labeled, including the D-loop, and four residues mutated to glutamines (aa57, 59, 67, and 71) are also shown.
(D and E) Front (D) and back (E) views are shown of Qc.
See also Figures S1–S3.
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Structure of an IcmR-IcmQ Complexhomology with NAD+ binding regions of secreted bacterial ADP
ribosyltransferases (ADPRTs), and binding experiments demon-
strated a dissociation constant (KD) for NAD
+ in the physiological
range. Modeling and molecular dynamics were then used
to generate a model of the Qc-NAD+ complex. This approach
revealed seven conserved residues that form an extended bind-
ing site for NAD+, and targeted point mutations in three of these
residues strongly reduced NAD+ binding. Finally, we show that
moderately conserved arginines in the linker helix may help
direct IcmQ to membranes. This may target IcmR-IcmQ to
the T4bSS, where the complex plays a critical role in the
translocase.
RESULTS
Structure of IcmR-IcmQ
IcmQ comprises an N-terminal domain (Qn; residues 1–57), a
trypsin-sensitive linker (residues 58–71), and a C-terminal
domain (residues 72–191) with a previously unknown fold. In
the present study, four basic linker residues (Lys57, Lys59,
Arg67, and Arg71) were mutated to glutamines to yield a
trypsin-resistant complex (denoted IcmR-IcmQ-tr; Figure 1A).
IcmQ-tr was coexpressed with IcmR-6xHis and purified by pull-
ing on the His-tagged complex. The protein complex was then
passed over HiTrap Q and HiTrap Sp columns (Figure 1B,
lanes 1–4). To facilitate crystallization, IcmR-IcmQ-tr complexes
were treated with protease to form trypsin-resistant complexes,1362 Structure 21, 1361–1373, August 6, 2013 ª2013 Elsevier Ltd Aldenoted Rm-IcmQ-tr, and the protease was then removed with
benzamidine agarose beads (Figure 1B, lane 5). Crystals of
the Rm-IcmQ-tr complex diffracted to 2.4 A˚ and were very sen-
sitive to oxidation, which necessitated using fresh crystallization
reagents. Leucine 119 of IcmQ and Leu84 in IcmR were mutated
to methionine, and crystals containing seleno-methionine-
labeled complexes were used to solve the structure with sin-
gle-wavelength anomalous scattering.
After refinement, the final model consists of residues 28–86 of
IcmR and residues 1–191 of IcmQ (see Table 1). The structure
revealed a two-domain complex separated by an extended
18-residue a helix (Figure 1C). This linker helix corresponds to
a trypsin-sensitive region between Qn and Qc (Dume´nil et al.,
2004) and contains four glutamine point mutations that were
introduced to confer trypsin resistance. It is intriguing that one
of the mutations (Gln67) was involved in a crystal contact
(Figure S1A available online). A structure of the IcmR-IcmQ
interacting region (denoted Rm-Qn) was solved previously (Ray-
chaudhury et al., 2009) and is present in the full complex (Fig-
ure 1C). In brief, two helices from each protein form a parallel
four-helix bundle with hydrophobic residues buried in the inte-
rior. The trypsin-sensitive linker between Qn and Qc forms an
extension of helix a2 and has been denoted helix a2L (Figure 1C,
residues 58–71). The Qc domain consists of residues 72–191
(Figures 1C–1E) and contains three b strands, two a helices,
and a loop shaped like the capital Greek letter delta (residues
136–165). The D-loop is well ordered due to extensive crystall rights reserved
Table 1. Crystallographic andRefinement Statistics for Rm-IcmQ
Data Sets
Parameters
Data Set
Native
Selenomethionine
Derivative
Space group P21212 P21212
Unit cell dimensions (A˚) 69 3 112 3 49 69 3 111 3 49
Cell angles () 90, 90, 90 90, 90, 90
Solvent content (%) 63 62
Vm (A˚3/Dalton) 3.32 3.24
Molecules/asu 1 1
Wavelength (A˚) 1.000 0.9789
I/s (total/highest) 20.8/5.4 27.6/9.3
Completeness 99.1 (99.6) 99.7 (99.4)
Rmerge (total/highest) 0.054/0.341 0.077/0.306
Refinement Statistics for the
Rm-IcmQ Native Data Set
Resolution range (A˚) 19.75–2.4
Unique reflections 15,065
Test set 1,560 (10%)
Rcryst 0.225
Rfree 0.259
Mean B value (A˚3) 45.6
rmsd
Bond length (A˚) 0.017
Bond angle () 1.72
Total waters 118
Residues modeled IcmQ, 1–100, 104–191; IcmR, 28–86
Residues omitted IcmQ, 101–103; IcmR, 1–27, 87–120
(removed by proteolysis)
Ramachandran plot
Core region 228 residues, 94.6%
Additional allowed regions 13 residues, 5.4%
asu, asymmetric unit.
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Structure of an IcmR-IcmQ Complexcontacts with a symmetry mate (Figures S1B and S1C) and
forms van der Waals contacts with other regions of Qc (Figures
1C–1E).
Molecular dynamics simulations of Rm-IcmQ suggest that the
linker helix may be flexible. This flexibility would allow the
Rm-Qn four-helix bundle to reorient relative to Qc (Figure S2A).
These movements are hinge-like and centered primarily at
Gly51 and Gly73 located at either end of helix a2L. Hence,
Rm-Qn and Qc may come into close contact in solution (Fig-
ure S2B). The physiological relevance of this flexibility is not
known. However, the B-factor distribution suggests that some
regions of Qc may be intrinsically flexible relative to the Rm-
Qn helix bundle (Figure S3). Higher B-factors could be due to
a lack of stabilizing crystal contacts or the absence of a suitable
ligand in the small loop-rich Qc domain. Finally, extensive con-
tacts between the linker helix and an adjacent molecule may
have stabilized the linker helix in a more extended conformation,
allowing the Rm-IcmQ complex to be crystallized (Figures S1B
and S1C).Structure 21, 1361An NAD+ Binding Fold in the C-Terminal Domain of IcmQ
Coordinates for the Qc domain were submitted to the DALI
server (Holm et al., 2008) to identify proteins with a similar fold,
and the results suggested possible roles for IcmQ. Based on
structural homology, a region of Qc was found to be similar to
ADPRT domains in certain bacterial toxins (Figures 2A–2C,
highlighted in gold). These toxin ADPRTs hydrolyze NAD+ and
transfer the ADP-ribose moiety to target proteins in host cells
(Koch-Nolte et al., 2001; Holbourn et al., 2006). This posttransla-
tional modification may result in misregulation of the target
protein. It is interesting that IcmQ is not believed to be exported
by Legionella into the host cytoplasm and, thus, may act within
the bacterium. Structures with similar NAD+ binding domains
include cholera toxin (Zhang et al., 1995; O’Neal et al., 2005)
and diphtheria toxin (Bennett et al., 1994) (Figures 2B and 2C),
with an overall sequence identity of 7%–13% and an average
root-mean-square deviation (rmsd) of 2.9 A˚ between the appro-
priate toxin regions and Qc. The ADPRT domains contain a
b-aa-bb motif, and each toxin has a unique region inserted
between b strands 2 and 3. The equivalent insert in IcmQ corre-
sponds to the D-loop (Figures 2A–2C, shown in gray). A binding
pocket for the nicotinamide-ribose moiety in ADPRTs has been
characterized as a ‘‘scorpion’’ motif with a loop or b strand con-
nected by a tight turn to an a-helix to form a hairpin-like structure
(Lee et al., 2010). Comparison of Qcwith NAD+-bound structures
of cholera and diphtheria toxins revealed a similar hairpin in the
three proteins (Figures 2D–2F).
The program BLAST (Altschul et al., 1990) was then used to
identify 54 IcmQ orthologs in five bacterial genera (Legionella,
Rickettsiella, Fluorobacter, Tatlockia, and Coxiella) that have
Type 4b secretion systems. IcmQ sequences were then aligned
with T-Coffee to reveal conserved residues (Figure 3A) (Notre-
dame et al., 2000). In total, seven residues that may form an
NAD+ binding surface were mapped onto the scorpion motif
and the surrounding region. These residues include Ser80,
Tyr82, Arg106, Tyr109, Lys122, Glu128, and Asp151 (marked
with black dots in Figure 3A). In addition, Pro107 and Ile108
form part of a conserved RPIY motif that is located on the loop
proximal to helix a4 in the scorpion motif (Figures 3A and 3B;
shown in gold). It is interesting that IcmQ lacks a conserved glu-
tamic acid residue that is usually adjacent to the scorpionmotif in
all known ADPRTs (Lee et al., 2010). The side chain carboxyl
group of glutamate destabilizes the N-glycosidic bond between
the ribose ring and nicotinamide, which facilitates an SN1 addi-
tion of the ribose-ADPmoiety to a side chain of the target protein
(Holbourn et al., 2006). We hypothesize that Asp151 in the D-
loop could perform a similar role in IcmQ.
NAD+ Binding to IcmQ
The similarity between Qc and ADPRTs prompted us to test
NAD+ binding by IcmQ. To this end, 15N-labeled Qc with the
linker helix (Qcl; residues 49/50 to 191) was probed using 2D
NMRbecause of the high solubility of this domain. Heteronuclear
single quantum coherence (HSQC) spectra were collected in a
titration series with increasing ratios of NAD+ to Qcl and the
resulting spectra were overlaid (Figure 4A, inset shown in 4B).
It is intriguing that only a small number of peaks shifted, suggest-
ing that a distinct and local conformational change may occur
upon NAD+ binding. Similar experiments with NADH showed–1373, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1363
Figure 2. The Qc Domain Shares Structural Homology with ADPRTs of bacterial toxins
(A) The Qc domain is shown with a region of structural homology to ADPRTs colored in yellow. The inserted region between b strands 2 and 3 contains theD-loop
colored in gray.
(B) A similar color-coded depiction is used for the ADPRT domain of cholera toxin (PDB ID 2A5F). Structures in (A), (B), and (C) have been aligned on their ADPRT
domains.
(C) The ADPRT domain from diphtheria toxin (PDB ID 1TOX) is shown.
(D) The scorpion motif in the Qc domain is highlighted.
(E) The cholera toxin (Ctx) scorpion motif (PDB ID 2A5F) is shown with bound NAD+, and the nicotinamide ring is labeled (NM).
(F) The diphtheria toxin (Dtx) scorpion motif (1TOX) is shown with bound NAD+.
Structure
Structure of an IcmR-IcmQ Complexno detectable peak shifts with 5 mM NADH (data not shown).
After plotting peak shifts as a function of NAD+ concentration,
we obtained an apparent KD in the range of 0.5–1 mM (Fig-
ure 4C). However, a nonspecific binding component is present,
which made curve fitting difficult. To quantitate NAD+ binding,
we carried out filter binding assays using 32P-labeled NAD+. After
subtraction of nonspecific binding from the experimental data
(Figure 4D, red and blue curves), a well fit hyperbolic curve
was obtained (Figure 4D, black triangles). Direct curve fitting
and Lineweaver-Burk analysis gave a KD of 0.4–0.6 mM (Fig-
ure 4E). Although this KD indicates a relatively low affinity, the
value falls in the middle of measured NAD+ concentrations in
bacteria, which may vary depending upon the metabolic state
of the cells (Grose et al., 2006). Hence, NAD+ binding by IcmQ
may be physiologically relevant.
We then attempted to determine the structure of Rm-IcmQ
with bound NAD+. Crystals of Rm-IcmQ soaked with NAD+
were stable up to a ligand concentration of 10 mM before
cracking or dissolving. Unfortunately, the diffraction quality of
these crystals was poor, so cocrystallization was attempted.
Crystals with the usual morphology grew in the presence of1364 Structure 21, 1361–1373, August 6, 2013 ª2013 Elsevier Ltd Al5 mM NAD+, but no density for the cofactor was found in the
resulting maps. This could be due to the fact that the NAD+ bind-
ing motif (specifically the D-loop that contains D151A) may be
involved in lattice contacts.
Therefore, computational methods were used to model NAD+
binding. First, a roughmodel with dockedNAD+was constructed
based on toxin cocrystal structures. Molecular dynamics
was then used to optimize the binding geometry (Figures 5A
and 5B). The resulting model suggests a number of plausible in-
teractions between NAD+ and conserved Qc residues, as high-
lighted in Figures 3 and 5. For example, Tyr82 and Tyr109 form
ring-stacking interactions with the adenine and nicotinamide
ring systems (Figures 5C–5F), while Arg106 and Lys122 may
form hydrogen bonds with phosphate groups (Figure 5D). In
addition, Ser80 and Glu128 form hydrogen bonds with suitable
partners in the nicotinamide and ADP-ribose moiety, respec-
tively (Figures 5C and 5E). It is important to note that Asp151
may form hydrogen bonds with both 20- and 30-hydroxyl groups
of the nicotinamide-ribose moiety (Figure 5F). This may destabi-
lize the N-glycosidic bond with nicotinamide to facilitate an SN1
mechanism, as suggested for other ADPRTs (Holbourn et al.,l rights reserved
Figure 3. Conserved Residues in the Qc
Domain May Play a Role in NAD+ Binding
(A) A structural alignment is shown for IcmQ se-
quences from five genera. Similar hydrophobic
residues are gray, positively charged residues are
light blue, negatively charged residues are orange,
and hydrophilic residues are green. Residues that
may interact with NAD+ are yellow and are marked
with a black dot.
(B) A back view of the Qc domain is shown.
Conserved residues in the vicinity of the scorpion
motif are labeled, and their side chains are yellow.
Structure
Structure of an IcmR-IcmQ Complex2006). Finally, the overall structures of apo- and NAD+-bound
Qc molecules are quite similar, as suggested by nuclear mag-
netic resonance (NMR) spectra. However, a small perturbation
of the D-loop (gray model in Figure 5A) is required to position
Asp151 to interact with bound NAD+. The D-loop forms ex-
tensive lattice contacts in the current crystal form. Thus,
loop movements required for NAD+ binding may have precluded
the formation of a liganded complex in crystal soaking
experiments.
To test the NAD+ binding model, a number of IcmQ mutants
were prepared with altered residues in the predicted bind-
ing site including constructs with D151A, D151G, D151S, and
Y82A/Y109A mutations. When overexpressed in E. coli, the
D151A, D151G, and D151S mutations gave insoluble proteins,
while Y82A/Y109A mutations were not expressed. However a
doublemutant of IcmQ (R106A/K122A) was prepared in complex
with IcmR, and the CD spectrum was similar to that obtained
with wild-type complexes (Figure S4). In addition, a soluble
D151A mutant of Qcl had a normal CD spectrum (Figure S4).
Wild-type and mutant proteins were then tested in filter binding
assays with 32P-labeled NAD+. In this assay, we also performed
competition experiments with cold (unlabeled) NAD+ and NADH
(50 mM) to test specificity. As shown in Figure 4F, only back-
ground binding of NAD+ was observed for the Qcl D151Amutant
and the IcmQ R106A/K122A double mutant relative to wild-type
proteins. There was no further reduction in NAD+ binding after
the addition of cold substrate. This supports our hypothesis
that D151, R106, and K122 may play important roles in NAD+
binding.Structure 21, 1361–1373, August 6, 2013 ªWe also found that NAD+ binding to
wild-type Qcl could be competed with a
large excess of cold NAD+ or NADH (Fig-
ure 4F), unlike the situation with NMR
binding experiments in which 5 mM
NADH did not cause peak shifts. A similar
binding profile was observed for wild-
type IcmR-IcmQ complexes. The
different NADH effects may be due to
the very different protein concentrations
used in NMR and filter binding experi-
ments, coupled with the likely presence
of a small amount of contaminating
NAD+ in the large excess of NADH used
in filter binding, whereas a much lower
concentration of NADH was used for the
NMR titration. Alternatively, NADH atvery high concentrations may bind to Qcl, but its lifetime may
preclude it from showing up on the NMR timescale. When taken
together, our data support the idea that Qcl and IcmQ may bind
NAD+, whereas NADH binding, if present, may be very weak.
To investigate the possible role of NAD+ binding, we created
an Lp02 strain in which the chromosomal copy of IcmQ was
replaced with a D151A mutant. However, as observed in over-
expression experiments, the IcmQ D151A mutant proved to
be less stable than wild-type protein, which resulted in much
lower levels of IcmQ in the mutant. Presumably, misfolded
IcmQ was rapidly degraded, leaving protein that was folded
and more stable. This mismatch in IcmQ levels, when compared
to wild-type Lp, would have made interpretations difficult. Thus,
we manipulated the expression of wild-type and IcmQ D151A in
separate Lp strains, so that these proteins were present in
similar amounts. We estimate that the steady-state level of
IcmQ in these cells was 5%–10% of that present in wild-
type cells (Figures S5A and S5B). We then assayed infectivity
with these matched Lp strains by monitoring the number of
bacteria in replication vacuoles after exposing mouse macro-
phages to postexponential bacteria. No discernible differences
in replication efficiency were found under these conditions (Fig-
ure S5C). This indicates that IcmQ levels present in wild-type Lp
are at least ten times more than is needed for growth within
mouse macrophages. Perhaps as little as 10–20 IcmQ mole-
cules per bacterial cell can maintain an intracellular growth
phenotype for Lp under these conditions. Additional studies
are now needed to work out the role of NAD+ binding and
IcmQ function in vivo.2013 Elsevier Ltd All rights reserved 1365
Figure 4. NAD+ Binding by IcmQ
(A) A titration of Qcl with NAD+ was monitored with 15N-HSQC spectra. The original sample contained 330 mM Qcl (red peaks). NAD+ was added to final con-
centrations of 330 mM (yellow), 390 mM (green), 620 mM (blue), 1.4mM (cyan), 3.3mM (magenta), and 7.7mM (black). A region of interest is boxed and shown in (B).
(B) Arrows indicate the direction of peakmovements in response to increasing NAD+ concentration. All spectra were acquired at 20C in 20mMphosphate buffer,
100 mM NaCl at pH 7.5.
(C) A plot is shown of peak shifts as a function of increasing NAD+ concentration for peak A. The apparent KD for NAD
+ binding is 0.5–1 mM.
(D) Fitted curves are shown for 32P-labeled NAD+ bound to Qcl in filter binding assays. A nonspecific component (red squares) was subtracted from the raw data
(dashed blue line) to give the corrected binding curve (black), with a calculated KD of 0.38 mM.
(E) A Lineweaver-Burk plot is shown for the corrected data, with a KD of 0.64 mM.
(F) A histogram is shown for NAD+ binding to wild-type, mutant Qcl, and double mutant IcmR-IcmQ, either alone (/) or in the presence of excess unlabeled
NAD+ or NADH. The mutant data are shaded in gray.
See also Figures S4 and S5.
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Structure of an IcmR-IcmQ ComplexMembrane Interactions of IcmQ
In a previous study, IcmQ was shown to bind to membranes and
permeabilize vesicles (Dume´nil et al., 2004). More recently,
membrane binding and permeabilization were shown to reside
in different domains of IcmQ. Thus, Qc with the linker helix (Qcl
49/50–191) directs membrane binding, while calcein efflux
from preloaded vesicles is dependent on the N-terminal domain
(Qn) (Raychaudhury et al., 2009).
We re-examined the ability of IcmQ to permeabilize mem-
branes and asked howmany molecules are required for this pro-
cess. We reasoned that fewer IcmQ molecules would be
required to form a defined membrane pore and release calcein
from vesicles than would be required in a carpet model (Shai,
2002). In the latter case, massive protein binding to the outer1366 Structure 21, 1361–1373, August 6, 2013 ª2013 Elsevier Ltd Alleaflet would destabilize the membrane, making it leaky. To
study this process, preformed lipid vesicles of 1 mm diameter
were formed by extrusion with a 3:1 ratio of
egg phosphatidylcholine:phosphatidylglycerol (PC:DMPG) and
loaded with calcein dye during extrusion (Dume´nil et al., 2004).
Increasing amounts of IcmQwere added to the vesicles, and cal-
cein efflux was followed by monitoring the increase in fluores-
cence of released dye. The resulting data are summarized in
Table S1. Calcein release is maximal at 50 nM IcmQ, which
corresponded to a calculated ratio of 2,800 molecules per
vesicle. This high ratio suggests that membrane permeabiliza-
tion by IcmQmay occur via the carpet mechanism. Since roughly
200 molecules of IcmQ may be present in each Legionella cell
(Dume´nil and Isberg, 2001), we surmise that membrane bindingl rights reserved
Figure 5. A Model of NAD+ Bound to Qc
(A) The structure of unliganded Qc (green) is
superimposed with the computational model of
NAD+ bound to Qc (gray). Note movement of the
D-loop and the extended conformation of NAD+
within the scorpion motif. In addition, the modeling
restored connectivity of the a3-a4 loop.
(B) Modeled NAD+ is shown in an extended
conformation bound to a surface groove on Qc.
(C–F) Possible molecular interactions between
NAD+ and Qc are shown in (C) through (F). In (C),
hydrogen bonds are depicted as black dashed
lines. Hydrogen bonding interactions between
Ser80 and nicotinamide in a small pocket are
shown. In addition, a ring-stacking interaction
between nicotinamide and Tyr109 is present. (D)
Hydrogen bonding between the phosphates of
NAD+ and Arg106/Lys122 is shown. (E) Ring
stacking between the adenine of NAD+ and Tyr82
is present, along with hydrogen bonding between
the ribosemoiety of ADP andGlu128. (F) Hydrogen
bonding is present between Asp151 and hydroxyl
groups of the ribose ring attached to the nicotin-
amide ring.
Structure
Structure of an IcmR-IcmQ Complexmay be the physiologically important property of IcmQ rather
than bilayer permeabilization.
In previous studies, we showed that Qn(1-57) and Qc(72-191)
did not bind to vesicles, while Qcl(49/50-191) did bind to mem-
branes (Dume´nil et al., 2004; Raychaudhury et al., 2009). This
suggested that residues involved in membrane binding may be
located between residues 49/50 and 71 in the a2L linker helix.
To identify specific residues, we tested IcmQ-tr with four basic
residues in the linker helix mutated to glutamine for membrane
binding with a vesicle floatation assay (Dume´nil et al., 2004).
Remarkably, IcmQ-tr was not able to associate efficiently with
membranes (Figure 6A, right panel) when compared to wild-
type IcmQ (Figure 6A, left panel). In addition, IcmQ-tr did not
release calcein from vesicles (Figure 6B, gray curve), presumably
because this molecule is not able to bind membranes. These
data suggest that basic residues in the linker helix of IcmQ-tr
may be responsible for membrane binding. Two moderately
conserved arginine residues in the linker helix (Arg67 and
Arg71; Figure S6A) are also present in Qn(1-72), which binds to
membranes (Dume´nil et al., 2004). Thus, Arg67 and Arg71 mayStructure 21, 1361–1373, August 6, 2013be required for membrane binding. To
ensure that diminished membrane bind-
ing was not due to large structural
changes introduced by linker mutations,
we obtained CD spectra for IcmQ and
IcmQ-tr, and the resulting spectra were
essentially identical (Figure S7). We also
examined the dependence of membrane
binding on acidic phospholipids and salt
concentration. When DMPG was omitted
during vesicle formation, we saw very little
binding of IcmQ to membranes (Fig-
ure 6C). In addition, vesicle binding was
greatly reduced in 250mMNaCl with ves-
icles made with DMPG and egg PC (Fig-ure 6D). Together, these data suggest that electrostatic interac-
tions are important for membrane binding by the rather basic
IcmQ molecule.
We have shown previously that IcmR-IcmQ will interact with
membranes (Raychaudhury et al., 2009). Thus, we used molec-
ular dynamics simulations to model the interaction of Rm-IcmQ
with a bilayer that contained POPG and POPE in the presence
of water and cations, beginning from a state in which the protein
was separated from the membrane by10–15 A˚ (Figure 6E, left).
During the simulations, basic residues near the end of the linker
helix (Arg67 and Arg71) may target the complex to the mem-
brane surface (Figure 6E, middle panel). In addition, the D-loop
also interacts with the charged membrane surface. After
650 ns, the entire Rm-Qn region and linker helix formed
numerous contacts with the head group region (Figure 6E, right
panel), and charged residues in contact with the membrane at
this point are shown in Figure S6B. The electrostatic surface
shows that the a2 linker helix is strikingly basic when compared
to the rest of the complex, while charged residues in Rm are not
well conserved. This charge distribution supports the idea thatª2013 Elsevier Ltd All rights reserved 1367
Figure 6. Membrane Binding of IcmQ
(A) IcmQ binds efficiently to floated vesicles (left), while IcmQ-tr does not bind to membranes and is present in the pellet (right) in this qualitative assay.
(B) IcmQ-tr (gray line) does not release calcein from vesicles, while IcmQ (blue line) is able to release trapped dye molecules as monitored by increased
fluorescence.
(C) IcmQ binding to vesicles is greatly diminished when membranes do not contain an acidic phospholipid.
(D) Higher salt diminishes IcmQ binding to vesicles made with an acidic phospholipid (DMPG).
(E) Molecular dynamics simulations show that Rm-IcmQ may bind to the membrane surface using electrostatic interactions.
See also Figures S6–S8 and Table S1.
Structure
Structure of an IcmR-IcmQ Complexthe basic linker helix is important in driving membrane associa-
tion. It is intriguing that the spacing between the two membrane
leaflets is perturbed when a large surface area of Rm-IcmQ is
bound to the bilayer. A similar local disordering of lipids may
lead to vesicle permeabilization when the bilayer is coated with
IcmQ molecules with an exposed and destabilizing Qn domain.
However, membranes are not permeabilized by IcmQ when
Rm or IcmR is bound to Qn because the amphipathic helix-
turn-turn helix motif of Qn is shielded from nonpolar regions of
the membrane, so cracks in the bilayer may not occur (Dume´nil
et al., 2004; Raychaudhury et al., 2009).
To examine whether membrane association of IcmQ is neces-
sary for translocation activity, we constructed a strain of Lp01,
with icmQ-tr replacing the chromosomal copy of icmQ (Lp01-
IcmQ-tr). Legionellae with an active T4bSS are sensitive to
NaCl concentrations greater than 0.1 M when grown on solid
media, which may be due to functional translocases providing
a conduit for salt entry into cells (Sadosky et al., 1993). Both1368 Structure 21, 1361–1373, August 6, 2013 ª2013 Elsevier Ltd AlLp01 and Lp01-IcmQ-tr were unable to grow on media contain-
ing 0.1 M NaCl (data not shown), indicating that assembled
translocases are present in both strains. In addition, protein
levels in Lp01-IcmQ-tr cells appeared to be normal (Figure S8A).
Translocation assays were performed to examine the effect of
membrane-deficient binding on IcmQ function. In these assays,
translocation of an adenyl cyclase construct (CyaA-MavU) from
Lp01-IcmQ-tr cells into macrophages was diminished by 50%
(Figure S8B), relative to the control. These data indicate that
membrane binding may increase the targeting efficiency of
IcmQ to the T4bSS, where it may interact with the translocase.
DISCUSSION
An NAD+ Binding Module in IcmQ
IcmQ is an essential protein in the T4bSS of Lp, as icmQ-defi-
cient strains are killed by host cells after phagocytosis (Coers
et al., 2000). In this article, we report a crystal structure ofl rights reserved
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Structure of an IcmR-IcmQ ComplexRm-IcmQ complexes that lack trypsin-sensitive N and C termini
of IcmR. This analysis shows that IcmR-IcmQ comprises two
domains separated by a trypsin-sensitive linker helix. IcmR
appears to be an integral part of the complex, as it chaperones
the amphipathic helix-turn-helix motif of Qn and prevents IcmQ
aggregation (Dume´nil and Isberg, 2001; Dume´nil et al., 2004;
Raychaudhury et al., 2009). The b-aa-bb motif in the C-terminal
domain of IcmQ has structural homology with ADPRT domains
of certain bacterial toxins (Koch-Nolte et al., 2001; Holbourn
et al., 2006) and is consistent with IcmQ having a scorpion motif
for NAD+ binding (Lee et al., 2010). We propose that Qc may
represent a minimal NAD+ binding module because the D-loop
between strands b2 and b3 is much smaller than similar inserts
in cholera and diphtheria toxins.
Sequence identity between Qc and ADPRTs is very low (7%–
13%). However, we were able to identify residues in IcmQ ortho-
logs from five bacterial genera that may be involved in NAD+
binding. We then demonstrated that Qc binds NAD+ with a KD
of 0.4–0.6 mM. While this value reflects a rather weak affinity,
the intracellular concentration of NAD+ in E. coli, a Gram-
negative bacterium like Lp, is 1–2 mM (Albe et al., 1990). After
identifying the scorpion motif, we used structural homology and
toxin-NAD+ cocrystal structures to create amodel of NAD+ bind-
ing to Qc. This model was refined with molecular dynamics to
provide a structure with reasonable stereochemistry in which
NAD+ adopts an extended conformation on the surface of Qc.
The analysis highlighted plausible roles for seven conserved res-
idues, including two tyrosines that may be involved in ring-stack-
ing interactions and five residues that could form hydrogen
bonds and salt bridges with NAD+. In particular, Asp151was pre-
dicted to form H-bond interactions with hydroxyl groups on the
ribose attached to nicotinamide, while two basic residues (Arg
106 and Lys122)may form a salt bridge networkwith phosphates
that link adenine-ribose and ribose-nicotinamide moieties. The
importance of Arg106, Lys122, and Asp151 was verified by a
significant loss of NAD+ binding after mutation of respective
residues to alanine. Of note, the distribution of putative ligand
binding residues on Qc differs from previously identified NAD+
binding motifs in ADPRTs (Holbourn et al., 2006).
Toward Identifying the Role of IcmR-IcmQ
Our work now sets the stage for further investigations into
the function of IcmR-IcmQ in the T4bSS. The fact that IcmQ
contains an NAD+ binding module suggests that this ligand
may regulate IcmQ function. The concentration of NAD+ varies
between 0.2 and 0.9mMunder anaerobic and aerobic conditions
in Salmonella enterica (Grose et al., 2006). Similar fluctuations
in the intracellular concentration of NAD+ may occur in Gram-
negative Legionella. Hence, a KD of 0.4–0.6 mM may be physio-
logically relevant, as variations in the intracellular NAD+ concen-
tration could influence the ratio of free and NAD+-bound IcmQ.
A recent study has shown that nicotinic acid (a precursor of
NAD+) is an important regulator of Lp virulence and can upregu-
late the transition from a replicating to a transmission phenotype
(Edwards et al., 2013). Addition of 5 mM nicotinic acid to expo-
nentially growing cultures induced a postexponential phenotype
with increased transcription of 39 virulence genes, including
icmB/DotO, icmD/DotP, and icmX along with components of
the core translocase icmG/DotF, icmJ/DotN, and icmO/DotLStructure 21, 1361(Vincent et al., 2006). This, in turn, promoted growth in macro-
phages and caused salt sensitivity for cell growth, which sug-
gests that a functional T4bSS had been assembled (Edwards
et al., 2013). Nicotinic acid also regulates virulence factors in
Bordetella pertussis (Cotter and DiRita, 2000; Miller et al.,
1989). These observations support the idea that the role of
IcmR-IcmQ in the T4bSS may be regulated by NAD+ levels.
There are two possible roles for IcmQ binding of NAD+. First,
IcmQ could be a specialized ADPRT that modifies T4bSS com-
ponents. All known ADPRTs have a conserved glutamic acid
that hydrogen bonds to hydroxyl groups of the ribose ring
attached to nicotinamide to destabilize the N-glycosidic bond
(Koch-Nolte et al., 2001; Holbourn et al., 2006; Jørgensen
et al., 2008). In our model, Asp151 in the D-loop may replace
this conserved glutamate, and a small rearrangement of the
D-loop may facilitate NAD+ binding. In some ADPRTs, a gluta-
mate to aspartate mutation leads to an inactive enzyme (Wilson
et al., 1990; Bo¨hmer et al., 1996). This inhibition may be due to
the shorter side chain of aspartate, which weakens its interaction
with boundNAD+. However, theD-loop inQc is probably flexible,
as our modeling shows that Asp151 can be brought into close
proximity to the ribose ring. This acidic residue is important for
NAD+ binding. However, our data show that the relatively unsta-
ble D151A variant has no impact on intracellular growth when
compared to amatchedwild-type strain, which also has a greatly
reduced expression of IcmQ. Trial assays with etheno-NAD+ and
model substrates, such as histones, arginine, or poly-L-lysine
showed no ADPRT activity. In addition, no NAD+ hydrolase activ-
ity could be detected (data not shown). Together, these data
argue against an enzymatic role for Asp151 in IcmQ.
In a second scenario, NAD+ binding may stabilize the Qc
domain, allowing IcmQ to function by interacting with a compo-
nent of the T4bSS. This idea is supported by data that show that
IcmQ stability is compromised by mutations that may block
NAD+ binding. Hence, Qc could act as a sensor that allows
IcmR-IcmQ to interact with a critical component of the T4bSS
when intracellular NAD+ levels are sufficient for binding. In
this model, low intracellular levels of NAD+ would lead to an
increased turnover of IcmQ, and this may occur during growth
conditions inwhich steady-state levels of other virulence-associ-
ated proteins are similarly reduced. The ability of the D151A
mutant to promote intracellular growth of Lp may reflect the
fact that a small pool of the protein is able to fold properly and
bind NAD+. This idea is compatible with our data, which show
a significant, though not complete, loss of NAD+ binding activity
in vitro (90%) by the D151A mutant.
The T4bSS must translocate protein effectors across three
membranes, but little is known about its overall structure (Fig-
ure 7). Functions have been assigned for some of the roughly
26 Dot and Icm proteins in the T4bSS (reviewed in Isberg et al.,
2009). The core translocase comprises Dot C, D, F, G and H (Vin-
cent et al., 2006; Nakano et al., 2010), while Dot U and IcmFmay
stabilize the assembly (Isberg et al., 2009). The trimeric Dot LMN
complex binds ATP and may act as a gatekeeper to the translo-
cation pore and coupling complex that interacts with IcmS-
IcmW, a receptor for protein effectors (Vincent et al., 2012; Ninio
et al., 2005). DotA is a candidate to interact with the host plasma
membrane, because it forms an oligomeric ring when it is
secreted in postexponential cells (Nagai and Roy, 2001).–1373, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1369
Figure 7. A Model of Membrane Localization and Possible Targeting of Rm-IcmQ to the T4bSS
IcmQ function may be modulated by the intracellular concentration of NAD+ in response to changes in the metabolic state of the bacterium (see Discussion).
Structure
Structure of an IcmR-IcmQ ComplexAgainst this backdrop, seven Dot/Icmproteinsmay have novel
functions in the T4bSS, because they are not present in bacterial
conjugation systems. These proteins include DotJ, DotU, DotV,
IcmF, IcmS, IcmR, and IcmQ (Komano et al., 2000; Sexton and
Vogel, 2002). The IcmR-IcmQ complex binds to membranes
that contain acidic phospholipids (Dume´nil et al., 2004). Mem-
brane binding by IcmQ may be directed by two moderately
conserved arginines in the linker helix. Notably, mutation of these
arginines led to a significant loss of translocation activity (50%)
without affecting IcmQ expression in Legionella.We suggest that
transient membrane binding may direct IcmR-IcmQ to the
T4bSS more efficiently, where the complex could interact with
(or perhaps modify) a target protein in the translocase (Figure 7).
This membrane targeting may be particularly important, given
the relatively low number of IcmQ molecules that are present in
each Lp cell (Dume´nil and Isberg, 2001). This work has now set
the stage for studies to further define the roles of IcmR-IcmQ
and NAD+ in the T4bSS.
EXPERIMENTAL PROCEDURES
Protein Preparation and Crystallization
UniProt accession numbers for IcmQ and IcmR are A5IHF0 and Q5ZYC9,
respectively. Expression clones of IcmR and IcmQ in the pQE-70 vector
(QIAGEN) with C-terminal 6xHis tags were provided by T. Montminy (Ray-
chaudhury et al., 2009). To facilitate coexpression, IcmQ lacking a 6xHis tag1370 Structure 21, 1361–1373, August 6, 2013 ª2013 Elsevier Ltd Alwas moved to the pET-24a vector. In order to generate a trypsin-resistant
version of IcmQ, Lys57, Lys59, Arg67, and Arg71 were mutated to glutamines
via PCR QuikChange reactions. For membrane binding experiments, these
mutations were also prepared in a construct of IcmQ containing a C-terminal
6xHis-tag. A construct of icmQ for phasing the Rm-Q crystals was generated
by mutating Leu119 to methionine using PCRmutagenesis. To create mutants
for NAD+ binding, we used QuikChange PCR to mutate Asp151, Arg106, and
Lys122, as well as Tyr82 and Tyr109 to alanines.
The Rm-IcmQ complex was prepared with BL21 (DE3) cells (Novagen),
which were transformed with pQE-70 IcmR-6xHis and pET-24a IcmQ-tr. Cells
were grown in the presence of 100 mg/ml ampicillin and 25 mg/ml kanamycin
in 1 l volumes of LB medium at 37C to an optical density at 600 nm of 1.0
and induced with 1mM isopropyl beta-thiogalactoside for 3 hr. Frozen cell pel-
lets were thawed and resuspended in 50 mM Tris (pH 8.0), 100 mM NaCl,
10 mMMgCl2, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM benza-
midine, 100 mM chymostatin, 1 mM leupeptin, and 125 mM aprotinin. To pro-
mote lysis, we treated cells with lysozyme (0.3 mg/ml lysate; Sigma), deoxy-
cholic acid (1.3 mg/ml), and DNase I (30 mg/ml; Sigma). High-speed lysate
(100,000 3 g) was bound to a HisTrap HP column (GE Biosciences) and
washed extensively prior to elution with 350 mM imidazole in 20 mM HEPES,
pH 7.2, 1.0 M NaCl. Eluted protein was dialyzed into a buffer consisting of
20 mM HEPES, pH 7.2, 50 mMNaCl, and 1 mM dithiothreitol (DTT) and further
purified by ion-exchange chromatography using HiTrap Q and HiTrap Sp
columns (GE Biosciences). The IcmR-IcmQ complex eluted from the HiTrap
Sp column in 900 mM NaCl. Trypsin (1,000:1 w/w; Sigma) was added to the
complex for 2 hr, prior to protease removal by passage over agarose-linked
benzamidine. The complex was then dialyzed into 20 mM Tris, pH 8.5,
50 mM NaCl, and 1 mM DTT; concentrated to 10 mg/ml; and stored until
used for crystallization. To prepare selenomethionine-incorporated Rm-IcmQ,l rights reserved
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Structure of an IcmR-IcmQ Complexwe replaced pET-24a IcmQ with pET-24a IcmQ (L119M) and pQE-70 IcmR-
6xHis contained an L84M mutation, as described elsewhere (Raychaudhury
et al., 2009). Transformed cells were grown in M9 minimal media (supple-
mented with selenomethionine) designed to inhibit the methionine biosyn-
thesis pathway (Doublie´, 1997), and IcmR-IcmQ complexes were prepared.
To make full-length IcmR-IcmQ, we performed a similar purification without
trypsinization. Complexes were concentrated prior to experiments with a
Centriprep. 15N-labeled Qcl protein (residues 49/50 to 191) for NMR studies
was expressed in M9 media supplemented with 15NH4Cl and purified as
described elsewhere (Raychaudhury et al., 2009). Unlabeled Qcl and a
D151A mutant of Qcl were also purified (Raychaudhury et al., 2009).
Crystals of native Rm-IcmQ were grown at 294 K in hanging drops at a con-
centration of 8 mg/ml in 24% polyethylene glycol (PEG) 1500, 100mMHEPES,
pH 7.5, 1 mM DTT, and 1% ethylene glycol. Crystals of the selenomethionine-
derivative Rm-IcmQ (L119M) were grown at 294 K in hanging drops (concen-
tration, 8mg/ml) in 24%PEG 1500, 100mMcitrate, pH 5.9, 1mMDTT, and 1%
ethylene glycol. To cryoprotect the crystals, equal volumes of buffer consisting
of 24% PEG 1500, 0.1 M HEPES, pH 7.2, or citrate, pH 5.9, 50 mM DTT, and
30% ethylene glycol were added to crystallization drops. Crystals were then
harvested using CryoLoops (Hampton Research), frozen in liquid nitrogen,
and stored until data collection.
Data Collection and Model Building
Native and derivative data sets were collected under nitrogen gas flow at 90 K
on beamline X25 at the National Synchrotron Light Source in 1 oscillations
using a ADSC Q315 CCD X-ray detector and processed with HKL-2000 (Otwi-
nowski and Minor, 1997). Initial attempts to phase the crystals using the
Rm-Qn 4-helix bundle (Protein Data Bank IDs 3FXD and 3FXE; Raychaudhury
et al., 2009) by molecular replacment were unsuccessful, as resulting electron
density in the Qc region was poor. Suitable initial electron density maps were
calculated using autoSHARP (Vonrhein et al., 2007) with a 3.0 A˚ selenomethio-
nine derivative data set. This revealed three major peaks, with each peak
arising from a selenium in selenomethionine residues that replaced methio-
nine, including M1 and L119M from IcmQ and L84M in IcmR. Phases were
improved and extended to 2.4 A˚ with SOLOMON (Abrahams and Leslie,
1996), with the native data set, and the model was built using COOT (Emsley
and Cowtan, 2004). For refinement, 10% of the data was excluded for calcu-
lation of R-free. The model was refined with PHENIX (Adams et al., 2010) using
iterative manual modifications, as well as ‘‘omit maps.’’ The final model
converged to an R-factor of 22.5% and an R-free of 25.9%. The Ramachan-
dran plot revealed 94.6% and 5.4% of the residues in the preferred and
allowed regions, respectively. Data collection and refinement statistics are
summarized in Table 1. All molecular figures were made with Chimera (Pet-
tersen et al., 2004).
Computational Modeling of the Qc-NAD+ Complex and Membrane
Binding by Rm-IcmQ
The NAD+-bound Qc was generated by starting from a rough model and
then undertaking multiple, successive rounds of refinement with molecular
dynamics simulations using NAMD (Phillips et al., 2005). Simulations ranged
from 50 to 500 ps in length, with varying levels of restraints applied to optimize
interactions between NAD+ and Qc. In the final step, NAD+ was freed
completely and found to remain bound for 50 ps. With the exception of a
portion of the D-loop, backbone atoms of Qc were restrained to their crystal-
lographic positions during refinement.
For the 50 ns simulation of IcmR bound to IcmQ without a bound ligand, a
system containing the two proteins in a water box was constructed and
ionized with K+ and Cl ions to a concentration of 100 mM. Solvation was
sufficient to maintain a minimum distance of 30 A˚ between periodic copies
of the proteins. The total system size was 57,000 atoms. For membrane-
binding simulations, a bilayer was constructed with POPG and POPE (1:2
ratio) to mimic the negative charge density of a bacterial membrane. Rm-
IcmQ was initially placed in a random orientation 10–15 A˚ distant from
the membrane surface. The system contained Ca2+ and Cl1 ions at a con-
centration of 100 mM, and the final system size was 130,000 atoms. The
first 50 ns of equilibration was carried out using NAMD on conventional
supercomputers, with the remaining 600 ns carried out using the special-
purpose molecular dynamics machine Anton (Shaw et al., 2009). SurfaceStructure 21, 1361charge distribution on the IcmR-IcmQ complex was calculated with APBS
(Baker et al., 2001).
Additional information is provided in the Supplemental Experimental
Procedures.
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